Managing Anemia in Patients with Hypothyroidism

Assessment and Monitoring Recommendations

The American Medical Association recommends ensuring TSH is within target range for the patient's clinical context 1
Investigation of other potential causes of anemia is necessary, including vitamin B12 deficiency, as recommended by the National Institute of Health 2
Monitoring reticulocyte count as a marker of erythropoiesis and response to therapy is suggested by the National Institute of Health 2
Repeat thyroid function tests and complete blood count at regular intervals (every 6-8 weeks during initial treatment), as advised by the American Medical Association 3

The American Medical Association suggests ensuring TSH is within reference range 1
Consideration of levothyroxine treatment for patients with subclinical hypothyroidism (TSH >10 mIU/L) may improve anemia response, as recommended by the American Medical Association 4 and 5
Administration of iron supplements at a different time than levothyroxine is necessary to prevent interference with absorption, as noted by the National Institute of Health 2

Pregnant women with hypothyroidism often require increased levothyroxine doses, and monitoring TSH every 6-8 weeks during pregnancy is recommended by the American Medical Association 3 and 6
Anemia management is particularly important during pregnancy due to increased demands, as emphasized by the American Medical Association 6

Consideration of erythropoietin therapy, particularly if significant urinary protein losses are present, is suggested by the National Institute of Health 2